Sophie Paczesny

Sophie Paczesny, M.D., Ph.D.


Professor
Pharmacology & Immunology
Cancer Focus

Understanding the mechanisms that regulate anti-cancer functions of immune cells and immune tolerance

Research Interest

I serve as a Co-Leader of the Cancer Biology and Immunology Program for the Medical University of South Carolina Hollings Cancer Center . I am a physician scientist pediatric hematologist with over 17 years research and training experience in immune-monitoring, immunotherapies, and biology of hematopoietic cell transplantation (HCT). My career focus is on both immunologic biomarker and cancer immune therapies. I have had consistent funding and publications in biomarkers for complications of therapies for cancer [i.e., graft-versus-host disease (GVHD)] as well as mechanistic studies in GVHD. I have worked on translation to novel immune therapies including development of small molecule inhibitors. My laboratory research is using advanced proteomics technology, and human studies, and laboratory research using in vivo experimental models to understand the biology of the discovered biomarkers. I have a commitment to the training of the next generation of physician scientists/translational scientists with a long track-record of mentoring. I am the PI on U01/R01s/R21, and PI/co-Investigator on several team science NIH-funded grants as well as foundation grants.

Positions and Scientific Appointments

2023-Present: Hollings Cancer Center Cancer Biology & Immunology Program Co-Leader, Medical University of South Carolina (MUSC), Charleston, SC 2023-Present: Professor, Department of Pharmacology and Immunology, MUSC, Charleston, SC 2020-Present: Sally Abney Rose Endowed Chair in Cancer Stem Cell Biology, MUSC, Charleston, SC 2020-2023: Hollings Cancer Center Cancer Immunology Program Co-Leader, MUSC, Charleston, SC 2020-2023: Professor and Chair of the Department of Microbiology and Immunology MUSC, Charleston, SC 2018-2023: Co-chair Immunobiology CIBMTR Working Group 2017-2020: Nora Letzter endowed Professorship of Pediatrics, Indiana University School of Medicine 2016-2021: ASH task force on Immunotherapies (co-chair) 2015-2020: Tenured Professor, Department of Pediatrics and Immunology, Indiana University 2013-Present: NIH 2014 Chronic GVHD consensus, Co-chair Biomarkers and Biology working committee 2012-2015: Associate Professor, Department of Pediatrics and Immunology, Indiana University 2010-2016: Scientific Committee on transplantation biology, American Society of Hematology, vice chair of the committee in 2015 and Chair in 2016 2009-2012: Assistant Professor tenure-track, Department of Pediatrics, University of Michigan 2007-2008: Visiting Scientist, Fred Hutchinson Cancer Research Center 2006-2009: Fellow, Department of Pediatrics, University of Michigan 2003-2005: Assistant Professor, University and Hospital of Nancy, Nancy, France

Education

Fellowship
April 2009
Proteomics/ Cell Transplantation
University of Michigan, Ann Arbor, MI
Visiting Scientist
August 2008
Clinical Proteomics
Fred Hutchinson Cancer Research Center, Seattle, WA
PhD
December 2004
Tumor Immunology
University of Paris VI, France
Fellowship
September 2003
Immunotherapy and Cancer Vaccines
Baylor Institute for Immunology Research, Dallas, TX
Fellowship
September 2000
Pediatric Hematology/Oncology
Hospitals of Paris, Paris, France
MS
July 1999
Cellular Therapy
University of Paris VII, France
Residency
September 1997
Pediatrics
Hospitals of Paris, Paris, France
MD
July 1995
Medicine
University of Strasbourg, France
BS
July 1989
Math/Life Sciences
Academia of Nancy-Metz, France